David MacDonald
Hoofd Techniek/Wetenschap/O&O bij XORTX THERAPEUTICS INC.
Actieve functies van David MacDonald
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| XORTX THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 20-01-2022 | - |
Loopbaan van David MacDonald
Eerdere bekende functies van David MacDonald
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Immunoflex Therapeutics, Inc. | Hoofd Techniek/Wetenschap/O&O | 01-01-2020 | 01-01-2021 |
| Biovail Contract Research Division | Corporate Officer/Principal | - | - |
Hemosol Corp. /Old/
 Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Hemosol Inc. is an integrated biopharmaceutical company focused on the development of a portfolio of products based on human hemoglobin. | Corporate Officer/Principal | - | - |
| Syntex, Inc. | Corporate Officer/Principal | - | - |
MSI Methylation Sciences, Inc.
 MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology MSI Methylation Sciences, Inc. engages in drug development through compound leverage. It focuses on developing pharmaceuticals based on molecules with proven efficacy that are under exploited in pharmaceutical markets. The firm offers s-adenosyl methionine, is a prescription drug used as a dietary supplement. The company was founded by Barry J. Guld and Nancy Harrison in 2006 and is headquartered in Burnaby, Canada. | Hoofd Techniek/Wetenschap/O&O | 01-01-2008 | 01-03-2017 |
| President | 01-03-2017 | - | |
Active Pass Pharmaceuticals, Inc.
 Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Active Pass Pharmaceuticals, Inc. develops drugs for infectious diseases. It engages in the development of drugs that inhibit ABC transporters. The firm also provides portfolio of therapeutic programs, including age-related macular degeneration, travelers' diarrhea, and lipid disorders. The company was founded by Peter B Reiner in 1998 and is headquartered in Vancouver, Canada. | Algemeen Directeur | 01-06-2004 | - |
| President | 01-06-2004 | - |
Opleiding van David MacDonald
| University of Alberta | Doctorate Degree |
Statistieken
Internationaal
| Canada | 9 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| President | 2 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 2 |
| Miscellaneous | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| XORTX THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
MSI Methylation Sciences, Inc.
MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology MSI Methylation Sciences, Inc. engages in drug development through compound leverage. It focuses on developing pharmaceuticals based on molecules with proven efficacy that are under exploited in pharmaceutical markets. The firm offers s-adenosyl methionine, is a prescription drug used as a dietary supplement. The company was founded by Barry J. Guld and Nancy Harrison in 2006 and is headquartered in Burnaby, Canada. | Health Technology |
Hemosol Corp. /Old/
Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Hemosol Inc. is an integrated biopharmaceutical company focused on the development of a portfolio of products based on human hemoglobin. | Health Technology |
Active Pass Pharmaceuticals, Inc.
Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Active Pass Pharmaceuticals, Inc. develops drugs for infectious diseases. It engages in the development of drugs that inhibit ABC transporters. The firm also provides portfolio of therapeutic programs, including age-related macular degeneration, travelers' diarrhea, and lipid disorders. The company was founded by Peter B Reiner in 1998 and is headquartered in Vancouver, Canada. | Health Technology |
| Syntex, Inc. | Miscellaneous |
| Biovail Contract Research Division | Commercial Services |
| Immunoflex Therapeutics, Inc. |
- Beurs
- Insiders
- David MacDonald
- Ervaring
